E. Freeman and K. Sherif, Prevalence of hot flushes and night sweats around the world: a systematic review, Climacteric, vol.6, issue.6, pp.197-214, 2007.
DOI : 10.1080/014436100434767

A. Welton, M. Vickers, J. Kim, D. Ford, and B. Lawton, Health related quality of life after combined hormone replacement therapy: randomised controlled trial, BMJ, vol.337, issue.aug21 2, p.1190, 2008.
DOI : 10.1136/bmj.a1190

C. Farquhar, J. Marjoribanks, A. Lethaby, J. Suckling, and Q. Lamberts, Long term hormone therapy for perimenopausal and postmenopausal women, Cochrane Database Syst Rev, vol.15, p.4143, 2009.

M. Canonico, E. Oger, G. Plu-bureau, J. Conard, and G. Meyer, Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study, Circulation, vol.115, issue.7, pp.840-845, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.642280
URL : https://hal.archives-ouvertes.fr/hal-00688234

J. Cauley, D. Seeley, W. Browner, K. Ensrud, and L. Kuller, Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures, Archives of Internal Medicine, vol.157, issue.19, pp.2181-2187, 1997.
DOI : 10.1001/archinte.157.19.2181

A. Paganini-hill, M. Corrada, and C. Kawas, Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study, Menopause, vol.13, issue.1, pp.12-18, 2006.
DOI : 10.1097/01.gme.0000172880.40831.3b

D. Petitti, J. Perlman, and S. Sidney, Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study, Obstet Gynecol, vol.70, pp.289-293, 1987.

C. Rodriguez, E. Calle, A. Patel, L. Tatham, and E. Jacobs, Effect of Body Mass on the Association between Estrogen Replacement Therapy and Mortality among Elderly US Women, American Journal of Epidemiology, vol.153, issue.2, pp.145-152, 2001.
DOI : 10.1093/aje/153.2.145

C. Chilvers, R. Knibb, S. Armstrong, K. Woods, and R. Logan, Post menopausal hormone replacement therapy and risk of acute myocardial infarction ??? a case control study of women in the East Midlands, UK, European Heart Journal, vol.24, issue.24, pp.2197-2205, 2003.
DOI : 10.1016/j.ehj.2003.09.019

F. Grodstein, J. Manson, and M. Stampfer, Hormone Therapy and Coronary Heart Disease: The Role of Time since Menopause and Age at Hormone Initiation, Journal of Women's Health, vol.15, issue.1, pp.35-44, 2006.
DOI : 10.1089/jwh.2006.15.35

L. Sourander, T. Rajala, I. Raiha, J. Makinen, and R. Erkkola, Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT), The Lancet, vol.352, issue.9145, pp.1965-1969, 1998.
DOI : 10.1016/S0140-6736(98)05066-1

G. Anderson, M. Limacher, A. Assaf, T. Bassford, and S. Beresford, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, vol.291, pp.1701-1712, 2004.

N. Cherry, K. Gilmour, P. Hannaford, A. Heagerty, and M. Khan, Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial, Lancet, vol.360, pp.2001-2008, 2002.

S. Hulley, D. Grady, T. Bush, C. Furberg, and D. Herrington, Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women, JAMA, vol.280, issue.7, pp.605-613, 1998.
DOI : 10.1001/jama.280.7.605

J. Rossouw, G. Anderson, R. Prentice, A. Lacroix, and C. Kooperberg, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA, vol.288, pp.321-333, 2002.

M. Vickers, A. Maclennan, B. Lawton, D. Ford, and J. Martin, Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women, BMJ, vol.335, issue.7613, p.239, 2007.
DOI : 10.1136/bmj.39266.425069.AD

J. Rossouw, R. Prentice, J. Manson, L. Wu, and D. Barad, Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause, JAMA, vol.297, issue.13, pp.1465-1477, 2007.
DOI : 10.1001/jama.297.13.1465

L. 'hermite, M. Simoncini, T. Fuller, S. Genazzani, and A. , Could transdermal estradiol+progesterone be a safer postmenopausal HRT? A review, Maturitas, vol.60, pp.185-201, 2008.

M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, and F. Robert, Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System, Endocrine Reviews, vol.28, issue.4, pp.387-439, 2007.
DOI : 10.1210/er.2006-0050

R. Prentice, R. Langer, M. Stefanick, B. Howard, and M. Pettinger, Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy between Observational Studies and the Women's Health Initiative Clinical Trial, American Journal of Epidemiology, vol.162, issue.5, pp.404-414, 2005.
DOI : 10.1093/aje/kwi223

A. Gompel, S. Rozenberg, and D. Barlow, The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy, Maturitas, vol.61, issue.3, pp.227-232, 2008.
DOI : 10.1016/j.maturitas.2008.10.009

H. Hodis and W. Mack, Coronary heart disease and hormone replacement therapy after the menopause, Climacteric, vol.12, issue.sup1, pp.71-75, 2009.
DOI : 10.1056/NEJMoa050613

S. Abbas, H. Brauch, J. Chang-claude, T. Dunnebier, and D. Flesch-janys, Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy, Int J Cancer, vol.126, pp.2935-2946, 2010.

D. Herrington, T. Howard, G. Hawkins, D. Reboussin, and J. Xu, Estrogen-Receptor Polymorphisms and Effects of Estrogen Replacement on High-Density Lipoprotein Cholesterol in Women with Coronary Disease, New England Journal of Medicine, vol.346, issue.13, pp.967-974, 2002.
DOI : 10.1056/NEJMoa012952

S. Silvestri, A. Thomsen, A. Gozzini, Y. Bagger, and C. Christiansen, Estrogen receptor ?? and ?? polymorphisms, Menopause, vol.13, issue.3, pp.451-461, 2006.
DOI : 10.1097/01.gme.0000182804.14385.a2

S. Almeida and M. Hutz, Genetic variation of estrogen metabolism and the risks of cardiovascular disease, Curr Opin Investig Drugs, vol.8, pp.814-820, 2007.

B. Katzenellenbogen, Dynamics of Steroid Hormone Receptor Action, Annual Review of Physiology, vol.42, issue.1, pp.17-35, 1980.
DOI : 10.1146/annurev.ph.42.030180.000313

D. Herrington, Role of estrogen receptor-?? in pharmacogenetics of estrogen action, Current Opinion in Lipidology, vol.14, issue.2, pp.145-150, 2003.
DOI : 10.1097/00041433-200304000-00005

3. The and . Group, Vascular factors and risk of dementia: Design of the three city study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

A. Alperovitch, M. Bertrand, E. Jougla, J. Vidal, and P. Ducimetiere, Do we really know the cause of death of the very old? Comparison between official mortality statistics and cohort study classification, European Journal of Epidemiology, vol.247, issue.6, pp.669-675, 2009.
DOI : 10.1007/s10654-009-9383-2

J. Ioannidis, I. Stavrou, T. Trikalinos, C. Zois, and M. Brandi, Association of Polymorphisms of the Estrogen Receptor ?? Gene With Bone Mineral Density and Fracture Risk in Women: A Meta-Analysis, Journal of Bone and Mineral Research, vol.85, issue.11, pp.2048-2060, 2002.
DOI : 10.1359/jbmr.2002.17.11.2048

A. Shearman, L. Cupples, S. Demissie, I. Peter, and C. Schmid, Association Between Estrogen Receptor ?? Gene Variation and Cardiovascular Disease, JAMA, vol.290, issue.17, pp.2263-2270, 2003.
DOI : 10.1001/jama.290.17.2263

M. Slattery, C. Sweeney, J. Herrick, R. Wolff, and K. Baumgartner, ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States, Breast Cancer Research and Treatment, vol.7, issue.10, pp.327-335, 2007.
DOI : 10.1007/s10549-006-9453-z

P. Alonso, M. Gratacos, C. Segalas, G. Escaramis, and E. Real, Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder, Psychoneuroendocrinology, vol.36, issue.4, pp.473-483, 2011.
DOI : 10.1016/j.psyneuen.2010.07.022

H. Maruyama, H. Toji, C. Harrington, K. Sasaki, and Y. Izumi, Lack of an Association of Estrogen Receptor ?? Gene Polymorphisms and Transcriptional Activity With Alzheimer Disease, Archives of Neurology, vol.57, issue.2, pp.236-240, 2000.
DOI : 10.1001/archneur.57.2.236

K. Rexrode, P. Ridker, H. Hegener, J. Buring, and J. Manson, Polymorphisms and Haplotypes of the Estrogen Receptor-?? Gene (ESR2) and Cardiovascular Disease in Men and Women, Clinical Chemistry, vol.53, issue.10, pp.1749-1756, 2007.
DOI : 10.1373/clinchem.2007.091454

L. Radloff, The CES-D Scale: A Self-Report Depression Scale for Research in the General Population, Applied Psychological Measurement, vol.1, issue.3, pp.385-401, 1977.
DOI : 10.1177/014662167700100306

M. Lawton and E. Brody, ASSESSMENT OF OLDER PEOPLE, Nursing Research, vol.19, issue.3, pp.179-186, 1969.
DOI : 10.1097/00006199-197005000-00029

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975.
DOI : 10.1016/0022-3956(75)90026-6

D. Commenges, L. Letenneur, P. Joly, A. Alioum, and J. Dartigues, Modelling age-specific risk: application to dementia, Statistics in Medicine, vol.17, issue.17, pp.1973-1988, 1998.
DOI : 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5

C. Viscoli, L. Brass, W. Kernan, P. Sarrel, and S. Suissa, Estrogen therapy and risk of cognitive decline: Results from the Women's Estrogen for Stroke Trial (WEST), American Journal of Obstetrics and Gynecology, vol.192, issue.2, pp.387-393, 2005.
DOI : 10.1016/j.ajog.2004.08.017

A. Fournier, S. Mesrine, M. Boutron-ruault, and F. Clavel-chapelon, Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?, Journal of Clinical Oncology, vol.27, issue.31, pp.5138-5143, 2009.
DOI : 10.1200/JCO.2008.21.6432
URL : https://hal.archives-ouvertes.fr/inserm-01319999

R. Prentice, J. Manson, R. Langer, G. Anderson, and M. Pettinger, Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause, American Journal of Epidemiology, vol.170, issue.1, pp.12-23, 2009.
DOI : 10.1093/aje/kwp115

G. Chen, Q. Zeng, and G. Tse, Estrogen and its receptors in cancer, Medicinal Research Reviews, vol.161, issue.S1, pp.954-974, 2008.
DOI : 10.1002/med.20131

N. Kobayashi, T. Fujino, T. Shirogane, I. Furuta, and Y. Kobamatsu, Estrogen receptor ?? polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen, Maturitas, vol.41, issue.3, pp.193-201, 2002.
DOI : 10.1016/S0378-5122(01)00287-0

S. Domingues-montanari, I. Subirana, M. Tomas, J. Marrugat, and M. Senti, Association between ESR2 Genetic Variants and Risk of Myocardial Infarction, Clinical Chemistry, vol.54, issue.7, pp.1183-1189, 2008.
DOI : 10.1373/clinchem.2007.102400

J. Ryan, I. Carriere, J. Scali, K. Ritchie, and M. Ancelin, Lifetime hormonal factors may predict late-life depression in women, International Psychogeriatrics, vol.109, issue.06, pp.1203-1218, 2008.
DOI : 10.1046/j.1525-1497.2000.04029.x
URL : https://hal.archives-ouvertes.fr/inserm-00337038